公开(公告)号：EP4511011A2

公开(公告)日：2025-02-26

申请号：EP23792817.1

申请日：2023-04-21

Applicant: Curio IP, LLC

Inventor： RUDNIC, Edward M. ,  BRONFEIN, Michael ,  GOLDBERG, Neil David

IPC: A61K9/20 ,  A61K47/38 ,  A61K31/352 ,  A61K47/32 ,  A61P25/20

公开(公告)号：EP4159203B1

公开(公告)日：2025-02-26

申请号：EP21841654.3

申请日：2021-05-25

Inventor： LIU, Feng ,  TAN, Xiaofeng ,  LIANG, Wenwei ,  ZHOU, Weijie ,  HUANG, Junlong

IPC: A61K9/16 ,  A61K9/20 ,  A61K9/22 ,  A61K9/26

公开(公告)号：EP3644977B1

公开(公告)日：2025-02-26

申请号：EP18739915.9

申请日：2018-06-29

Inventor： WEN, Shu-Fang ,  HUANG, Kuo-Kuei ,  PAN, I-Hong ,  LIN, Meng-Nan ,  LU, I-Huang ,  KUO, Zong-Keng ,  LU, Chu-Hsun ,  LEE, Tze- Chung ,  YANG, Ya-Yan ,  LIAW, Jia-Horng ,  LIN, Pei-Hsin ,  LO, Jir-Mehng

IPC: A61K31/045 ,  A61P25/28 ,  A61K31/352 ,  A61K31/335 ,  A61K31/215 ,  A61K31/122 ,  A61K9/20 ,  A61K9/08 ,  A61K31/047 ,  A61K31/075 ,  A61K31/222 ,  A61K31/343 ,  A61P37/00 ,  A61K9/00 ,  A61K9/50

公开(公告)号：EP4507680A1

公开(公告)日：2025-02-19

申请号：EP23720546.3

申请日：2023-04-13

Applicant: Bluestone Pharma GmbH

Inventor： GAVRILOVIC, Danijela ,  DMITROVIC, Milan ,  FABER, Michael ,  BRANDT, Karsten

IPC: A61K9/20 ,  A61K45/06 ,  A61K35/00 ,  A61P1/00

公开(公告)号：EP2767285B2

公开(公告)日：2025-02-19

申请号：EP12840025.6

申请日：2012-10-12

Inventor： INOUE, Yoshiharu

IPC: A61K9/20 ,  A61K9/28 ,  A61K31/496 ,  A61K47/02 ,  A61K47/10 ,  A61K47/12 ,  A61K47/26 ,  A61K47/38

公开(公告)号：EP4504176A1

公开(公告)日：2025-02-12

申请号：EP23781936.2

申请日：2023-04-03

Applicant: Agenebio, Inc. ,  The Johns Hopkins University ,  The Medical College of Wisconsin, Inc.

Inventor： GALLAGHER, Michela ,  LI, Shi-Jiang ,  BAKKER, Arnold ,  ROSENZWEIG-LIPSON, Sharon

IPC: A61K31/4015 ,  A61K9/00 ,  A61K9/20 ,  A61K9/28 ,  A61K31/5517 ,  A61P25/28

公开(公告)号：EP4461357A3

公开(公告)日：2025-02-12

申请号：EP24197031.8

申请日：2017-10-12

Applicant: Global Blood Therapeutics, Inc.

Inventor： DALZIEL, Sean Mark ,  BEJUGAM, Naveen ,  HABIBIZAD, Nazila ,  KOMEYLI, Ali ,  LEUNG, DeMei

IPC: A61K9/20 ,  A61K31/4439 ,  A61P7/06 ,  A61P11/00

Abstract: Provided herein are high strength/high drug load tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde ("Compound 1"), dispersible tablets comprising Compound 1, processes of manufacturing such tablets, and methods for treating patients with the tablets. Compound 1 is useful for treating hematological disorders such as sickle cell disease, pulmonary disease such as idiopathic pulmonary fibrosis, and hypoxia and hypoxemia conditions.

公开(公告)号：EP3720496B1

公开(公告)日：2025-02-05

申请号：EP18821993.5

申请日：2018-12-07

Inventor： NIELSEN, Bruno Provstgaard ,  NIELSEN, Kent Albin

IPC: A61K47/02 ,  A61K9/00 ,  A61K9/14 ,  A61K9/20 ,  A61K31/465 ,  A61P25/34

公开(公告)号：EP3453403B1

公开(公告)日：2025-01-22

申请号：EP18195610.3

申请日：2009-04-02

Inventor： FRIEDL, Thomas ,  BRAUN, Michael ,  EGUSA, Kenji ,  FUJITA, Hikaru ,  MARUYAMA, Megumi ,  NISHIOKA, Takaaki

IPC: A61K45/06 ,  A61K47/18 ,  A61K9/16 ,  A61K9/20 ,  A61K9/24 ,  A61K31/155 ,  A61K31/522 ,  A61P3/04 ,  A61P3/10 ,  A61P19/10 ,  A61P29/00 ,  A61P37/06 ,  A61P43/00 ,  A61P19/02

公开(公告)号：EP4491177A1

公开(公告)日：2025-01-15

申请号：EP24181116.5

申请日：2024-06-10

Applicant: Sanovel Ilac Sanayi ve Ticaret A.S.

Inventor： SUNEL, Fatih ,  BILGEHAN ATAK, Fadime ,  ATAMAN, Seval ,  DERELI, Selin

IPC: A61K9/20 ,  A61K31/4015

Abstract: The present invention relates to a film coated tablet comprising brivaracetam at least one pharmaceutically acceptable excipient wherein brivaracetam has a d (0.9) particle size between 100 µm to 300 µm and the amount of disintegrant is 2.0% to 7.0% by weight in the total composition. Furthermore, the tablet is also obtained by using an effective process which is simple, rapid, cost effective, time-saving and industrially convenient process.